A new clinical trial aims to investigate the effectiveness of Rise&Walk InHome, a cost-efficient gait training device designed for stroke survivors to use at home. The trial is sponsored by Healing Innovations, Kessler Foundation, and NICHD, with recruitment set to begin soon. This innovative approach targets motor recovery and improved mobility for individuals coping with post-stroke disabilities.
What changed?
The upcoming clinical trial introduces a practical, at-home rehabilitation device to support stroke survivors with gait disorders and mobility challenges. The Rise&Walk InHome solution by Healing Innovations is designed to empower users’ recovery from the comfort of their home, offering a cost-effective alternative to traditional therapy.
This study aims to address some of the most pressing challenges for stroke recovery, including balance impairment, walking difficulties, and motor function deficits, using innovative technology.
How does the device work?
The Rise&Walk InHome device facilitates gait training by targeting the neuromuscular systems affected by stroke. While exact details are yet to be published in trial data, similar technologies often employ biomechanical feedback, motor control principles, and balance enhancement mechanisms to aid recovery.
This device is specifically positioned for use within a patient’s home. Such innovations may improve adherence to therapy by addressing barriers like travel limitations, cost of outpatient care, and access to therapists.
What to expect from the trial?
The trial will assess the safety, performance, and patient outcomes of the device among individuals experiencing stroke-related functional challenges, including hemiparesis, fatigue, and other neurological gait disorders. Clinical endpoints are likely to focus on improved walking capacity, reduced fatigue, and motor recovery.
The study is currently listed as “Not yet recruiting” and will provide critical data on the device’s usability, effectiveness, and real-world applications.
The collaboration between Healing Innovations, the Kessler Foundation, and NICHD underscores the significance of developing patient-centric rehabilitation tools. Both clinical and regulatory stakeholders will be closely following the trial’s impacts on future stroke recovery protocols.
FAQs
- When does the trial begin? The trial is marked as “Not yet recruiting” as of this publication date. further details are anticipated soon.
- Who is eligible? Stroke survivors experiencing motor recovery challenges, gait disorders, or balance impairments may qualify. Final eligibility criteria will be outlined during recruitment.
- Who sponsors the study? The study is sponsored by Healing Innovations, Kessler Foundation, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Conclusion
Rise&Walk InHome represents a promising step in stroke rehabilitation, offering a home-based solution to improve mobility and recovery. This clinical trial will provide new insights into its safety, accessibility, and effectiveness as the field increasingly values patient-friendly, cost-effective medical devices.
Disclaimer
This article is for informational purposes only. It does not constitute legal or regulatory advice and should not be used as a substitute for consultation with compliance professionals.
Announcement and link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07250425?term=medical+device